From the beginning of July, Sarah Gordon Wild will be an Independent non-Executive Director at Redx Pharma in Alderley Park, UK.
ADVERTISEMENT
Aviv Regev will follow Michael Varney as Head of Genentech Research and Early Development (gRED) at Roche subsidiary Genentech. Varney will retire from the company at the end of July.
Montpellier-based Deinove has named a new Chief Executive Officer. Alexis Rideau took over the helm of the company in the beginning of May.
London-based Syncona Ltd announces the appointment of Danny Bar-Zohar as Syncona Partner, starting mid of April.
Medicen Paris Region, the health innovation hub in Île-de-France, announces the appointment of Jessica Leygues as CEO.
Carrie Brownstein has started as the new Chief Medical Officer at Cellectis, a French biopharmaceutical company.
Mark Beards is the new CEO of Sutura Therapeutics Ltd in Birkenhead (UK).
In October 2019, Thierry Bernard provisionally took over the responsibilities of Qiagen CEO Peer Schatz, who had left the company unexpectedly after 27 years.
Mark Truesdale has been appointed to the position of CEO at Life Sciences company Solentim.
CTO Lars Nieba has taken over as interim CEO at Nordic Nanovectors after Eduardo Bravos sudden departure.